Enanta Pharmaceuticals, Inc.
USD12.03
-0.64 (-5.05%)
CEO
Jay R. Luly
IPO Date
2013-03-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$12.51
Prev. Close
$12.67
Day Low
$11.91
Day High
$12.75
52W Low
$6.38
52W High
$17.15
Market Cap
$0.28B
Volume
0.19M
| 20,000 |
| $14.17 |
| 13 Mar 2026 | Peterson Kristine | director | A-Award | Acquired | 20,000 | $14.17 |
| 13 Mar 2026 | Hata Yujiro S | director | A-Award | Acquired | 20,000 | $14.17 |
| 13 Mar 2026 | FOLETTA MARK G | director | A-Award | Acquired | 20,000 | $14.17 |
| 13 Mar 2026 | CARTER BRUCE L A | director | A-Award | Acquired | 20,000 | $14.17 |
| 13 Feb 2026 | Kowalsky Matthew Paul | Chief Legal Officer | F-InKind | Disposed | 1,902 | $14.25 |
| 13 Feb 2026 | Kowalsky Matthew Paul | Chief Legal Officer | A-Award | Acquired | 1,318 | $0.00 |
| 13 Feb 2026 | Kowalsky Matthew Paul | Chief Legal Officer | A-Award | Acquired | 4,175 | $0.00 |
| 13 Feb 2026 | Luu Brendan | Chief Business Officer | A-Award | Acquired | 1,575 | $0.00 |